Pfizer Moves to Intervene in High-Profile Case Dealing With COVID-19 Vaccine Safety Data

Pfizer CEO Albert Bourla in Thessaloniki, Greece, on Oct. 12, 2021. Sakis Mitrolidis/AFP via Getty Images

Pfizer has asked a federal court to let it intervene in a high-profile case that has seen U.S. drug regulators try to slow-walk disclosure of data on Pfizer’s COVID-19 vaccine.

Pfizer says it supports disclosing the data but wants to ensure that information exempt from disclosure under the Freedom of Information Act (FOIA) is not “disclosed inappropriately.”